14-day Premium Trial Subscription Try For FreeTry Free
Microsoft acquires Activision (ATVI) in a $68.7 billion deal. MSFT expects to strengthen its gaming presence and enter the metaverse with strong franchises.
Biotech stocks pulled back yet again during the week ending Jan. 21, with the sector retreating along with the broader market. The news flow tapered off following the frenetic pace of the week that

Why Zogenix Flew Higher Before Leveling Off This Week

01:33pm, Friday, 21'st Jan 2022 The Motley Fool
The company attracts a determined suitor from abroad.
The company attracts a determined suitor from abroad.
Which biotech stocks are you watching today?

Biotech Stock Roundup: ZGNX's Acquisition News, REGN, BLUE's Updates & More

05:51pm, Thursday, 20'th Jan 2022 Zacks Investment Research
Regulatory and other pipeline updates from Zogenix (ZGNX) and Regeneron (REGN) are among a few key highlights from the biotech sector during the past week.

Zogenix (ZGNX) Stock Surges on Acquisition Offer From UCB

04:28pm, Thursday, 20'th Jan 2022 Zacks Investment Research
Belgium-based UCB is set to acquire Zogenix (ZGNX) for a total transaction value of $1.9 billion in cash. The transaction is likely to be completed by second-quarter 2022.

Zogenix (ZGNX) Stock Jumps 65.7%: Will It Continue to Soar?

01:35pm, Thursday, 20'th Jan 2022 Zacks Investment Research
Zogenix (ZGNX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in
Belgium-based UCB is set to acquire Zogenix (ZGNX) for a total transaction value of $1.9 billion in cash. The transaction is likely to be completed by second-quarter 2022.
Zogenix (ZGNX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in
U.S. stock indexes close lower Wednesday, with the Nasdaq Composite ending in correction territory for the first time since March, as sharply higher bond yields and elevated inflation rattle markets.
Zogenix (ZGNX) stock is skyrocketing on Wednesday following news that UCB (UCBJY) intends to acquire the company in a $1.9 billion deal.

Xenon draws buyout speculation after Zogenix deal

03:51pm, Wednesday, 19'th Jan 2022 Seeking Alpha
Dealreporter flags Xenon Pharmaceuticals <> as a potential acquisition target following the agreement between Zogenix <> and UCB under which the Belgian drugmaker offered

Why Zogenix Stock Is on Fire Today

03:18pm, Wednesday, 19'th Jan 2022 The Motley Fool
A buyout deal is lighting a fire underneath the biotech's shares today.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE